StreetAlpha
13F holdings · Q3 2026

Montanova Capital

New York, NY · files as Montanova Capital, LLC
Know the moment Montanova Capital filesYou follow Montanova Capital An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 1569064

Montanova Capital reported 88 stocks worth $3.6B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are MANE (12.4%), ARQT (8.9%) and NVDA (4.4%). Compared with Q2 2026, the fund opened new positions in CCL, BURL and RCL, added to AVBP, SYY and REPL, trimmed MANE, ARQT and NVDA and sold out of AMD, RCUS and CAPR.

Latest filing: what Montanova Capital did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
11 new17 added29 trimmed18 sold outBought about $369M · sold about $1B
New 11
See all 11 →
Added 17
See all 17 →
Trimmed 29
  • HD−$62.8M−98%
  • COF−$62.6M−97%
  • MANE−$54.6M−11%
  • HUT−$30.1M−52%
  • AURA−$28.6M−63%
See all 29 →
Sold out 18
See all 18 →

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$3.6B−23.8% vs last quarter · $4.3B including options
Stocks held8811 new · 18 sold out
Top 5 weight33.9%spread out
Turnover38%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
MANE
Veradermics Inc
$451M12.4%3.7M−450K (−11%)3 of 8
2
ARQT
Arcutis Biotherapeutics Inc
$324M8.9%12.3M−168K (−1%)8 of 8
3
NVDA
Nvidia Corporation
$160M4.4%702K−19K (−3%)8 of 8
4
AVBP
Arrivent Biopharma Inc
$149M4.1%4.9M+410K (+9%)8 of 8
5
PVLA
Palvella Therapeutics Inc NE
$144M4.0%1M−91K (−8%)8 of 8
6
BHVN
Biohaven Ltd
$137M3.8%10.3MNo change8 of 8
7
TSM
Taiwan Semiconductor Mfg Ltd
$134M3.7%293K−12K (−4%)8 of 8
8
META
Meta Platforms Inc
$127M3.5%176KNo change8 of 8
9
LEGN
Legend Biotech Corp
$124M3.4%6.2M−840K (−12%)8 of 8
10
BNTC
Benitec Biopharma Inc
$115M3.2%11.5MNo change8 of 8
🔒 78 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
AMD
Advanced Micro Devices Inc
$149M257K
RCUS
Arcus Biosciences Inc
$147M4.8M
CAPR
Capricor Therapeutics Inc
$98.6M4.1M
FERG
Ferguson Enterprises Inc
$58.6M247K
CRINETICS PHARMACEUTICALS IN
$44.4M1.2M

🔒 Free account: see all 18.

Options

valued at the underlying shares
StockTypeValueSharesChange
QQQ
Invesco Qqq TR
Put$481M650K+650,000
SPY
Spdr S&P 500 ETF TR
Put$191M250K−700,000

Reported value

last 8 quarters
$2.7BQ4 '24
$2.5BQ1 '25
$2.7BQ2 '25
$3.3BQ3 '25
$4BQ4 '25
$3.7BQ1 '26
$4.8BQ2 '26
$3.6BQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Montanova Capital 13F FAQ

What does Montanova Capital own?

Montanova Capital reported 88 stocks worth $3.6B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are MANE (12.4%), ARQT (8.9%) and NVDA (4.4%). The table above lists every position in the filing (the top 10 without an account).

What did Montanova Capital buy and sell in Q3 2026?

Compared with Q2 2026: 11 new positions, 17 added to, 29 trimmed and 18 sold out. New positions include CCL, BURL and RCL. It sold all of AMD, RCUS and CAPR.

When will Montanova Capital file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Montanova Capital's portfolio worth?

The Q3 2026 filing reports $3.6B in US stocks ($4.3B including options). That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.